ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Conceptual Extension of SNP Based Abundance Profiling to Infer Donor Derived Cell-Free DNA Fraction as an Indication of Organ Rejection

R. Sinha, K. Mickey, J. Grantham, M. Wissel, M. Altrich, S. Kleiboeker

R&D, Viracor-Eurofins, Lee's Summit, MO

Meeting: 2019 American Transplant Congress

Abstract number: A21

Keywords: Bone marrow transplantation, Graft acceptance, Graft failure, Graft survival

Session Information

Date: Saturday, June 1, 2019

Session Name: Poster Session A: Acute Rejection

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall C & D

Related Abstracts
  • Early Detection of Xenograft Rejection or Injury by Donor Derived Cell Free DNA in Pig to Baboon Cardiac Xenotransplantation.
  • Donor-Derived Cell-Free DNA Is a Dynamic Biomarker of Active Rejection in Kidney Allografts.

*Purpose: Rejection is a major post-transplant complication for organ transplant recipients. Biopsy remains the standard to diagnose rejection, but other non-invasive methods, such as transcript levels, cytokine biomarkers and detection of donor derived cell-free DNA (ddcfDNA) have been studied. An ideal method would be sensitive, specific, objective, non-invasive, cost-effective and be able to detect early rejection. Inferring the proportion of ddcfDNA in plasma is a powerful, non-invasive diagnostic method. A higher proportion of ddcfDNA correlates with a higher probability of organ rejection.

*Methods: Here we present a novel method for rapid ddcfDNA prediction using a bioanalytics pipeline which can predict the proportion of ddcfDNA, with inputs of low-depth, whole genome next generation sequencing (NGS) data of cell-free DNA (cfDNA) and the genotype of the recipient, within two hours. The cfDNA extracted from plasma collected in Streck BCT tubes is used to prepare libraries for analysis on the Illumina NextSeq. Recipient genotypes were determined using the Infinium Omni2.5-8 beadchip array, which interrogates approximately 2.5 million single-nucleotide polymorphism loci. The core prediction-pipeline is an extension of the SIGMA protocol (https://sigma.omicsbio.org), originally designed to calculate the proportion of microbial abundance at the strain level using metagenomic NGS reads. While the original method required the presence of the genomic sequences as a reference-set, our pipeline generates the required reference sequences (recipient and donor genomes) using cfDNA NGS data and the genotype of the recipient.

*Results: We tested 15 sets of simulated ad-mixtures of donor and recipient NGS reads, where donor fractions and read-pair counts ranged from 0.49% – 16.6% and 954,662 – 1,569,663, respectively. Computationally derived donor/recipient reference genomes, covering SNP loci homozygous to recipient, were comprised of ~1.3M bases. Given the relatively small sizes of reference genomes, the run time of the prediction module was ~10 minutes (15 CPUs/10GB RAM), and the whole simulation process for a single test set required ~30 minutes. Our predictions had strong correlation (r2=0.99) with the simulated proportions of the donor cell-free DNA reads in the mix.

*Conclusions: In summary, our conceptual model yields accurate results, significantly reducing the computational time required compared to published methods.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Sinha R, Mickey K, Grantham J, Wissel M, Altrich M, Kleiboeker S. Conceptual Extension of SNP Based Abundance Profiling to Infer Donor Derived Cell-Free DNA Fraction as an Indication of Organ Rejection [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/conceptual-extension-of-snp-based-abundance-profiling-to-infer-donor-derived-cell-free-dna-fraction-as-an-indication-of-organ-rejection/. Accessed March 1, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Enhanced Recovery after Surgery Protocols in Kidney Transplantation: Time to Change Practice?
  • Efficacy of Filgrastim in Solid Organ Transplant Recipients
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • #16789 (not found)
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.